# OnCo record thymic-carcinoma (cancer). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/cancers/thymic-carcinoma/>
  a schema:MedicalCondition ;
  onco:kind "cancer" ;
  schema:identifier "thymic-carcinoma" ;
  schema:name "Thymic carcinoma"@en ;
  schema:alternateName "Thymic squamous cell carcinoma"@en, "Type C thymoma (obsolete)"@en, "Thymic carcinoma"@en, "Malignant thymic epithelial tumour"@en ;
  schema:description "Thymic carcinoma is the aggressive kind of thymic epithelial tumour, a cancer of the thymus that behaves like carcinoma elsewhere and has often spread when found. Surgery is attempted when possible, carboplatin with paclitaxel is the usual chemotherapy, and sunitinib, lenvatinib and the PD-1 antibody pembrolizumab have shown responses in trials, with lenvatinib approved in Japan."@en ;
  schema:url <https://onco.cc/cancers/thymic-carcinoma/> ;
  schema:dateModified "2026-09-18"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/Thymic_carcinoma> ;
  schema:citation <https://doi.org/10.1016/S1470-2045(20)30162-5>, <https://doi.org/10.1016/S1470-2045(18)30062-7>, <https://en.wikipedia.org/wiki/Thymic_carcinoma> ;
  onco:tag "subtype-page", "thoracic" ;
  onco:related <https://onco.cc/cancers/thymoma/>, <https://onco.cc/cancers/thymic-epithelial/>, <https://onco.cc/cancers/extrapulmonary-nec/> ;
  onco:technologies <https://onco.cc/technologies/robotic-surgery/>, <https://onco.cc/technologies/imrt-igrt/>, <https://onco.cc/technologies/proton-therapy/>, <https://onco.cc/technologies/kinase-inhibitors/>, <https://onco.cc/technologies/checkpoint-inhibitor/>, <https://onco.cc/technologies/cytotoxic-chemotherapy/> ;
  onco:targets <https://onco.cc/targets/kit/>, <https://onco.cc/targets/pd1/>, <https://onco.cc/targets/vegf/> ;
  onco:drugs <https://onco.cc/drugs/carboplatin/>, <https://onco.cc/drugs/paclitaxel/>, <https://onco.cc/drugs/cisplatin/>, <https://onco.cc/drugs/doxorubicin/>, <https://onco.cc/drugs/cyclophosphamide/>, <https://onco.cc/drugs/sunitinib/>, <https://onco.cc/drugs/lenvatinib/>, <https://onco.cc/drugs/pembrolizumab/>, <https://onco.cc/drugs/everolimus/>, <https://onco.cc/drugs/imatinib/> ;
  onco:terms <https://onco.cc/terms/irae/>, <https://onco.cc/terms/tmb/>, <https://onco.cc/terms/staging-systems/> ;
  onco:trials <https://onco.cc/trials/nct05683886/>, <https://onco.cc/trials/nct07324629/>, <https://onco.cc/trials/nct07598955/> ;
  onco:keyPapers <https://onco.cc/key-papers/paper-remora-lenvatinib-thymic-carcinoma-lancet-oncol-2020/>, <https://onco.cc/key-papers/paper-giaccone-pembrolizumab-thymic-carcinoma-lancet-oncol-2018/>, <https://onco.cc/key-papers/paper-esmo-thymic-epithelial-tumours-guideline-ann-oncol-2015/>, <https://onco.cc/key-papers/paper-who-2021-thymus-mediastinum-classification-marx-jto-2022/> ;
  onco:pipeline <https://onco.cc/drugs/lenvatinib/>, <https://onco.cc/drugs/sunitinib/>, <https://onco.cc/drugs/pembrolizumab/>, <https://onco.cc/drugs/kc1036/>, <https://onco.cc/drugs/eb-car30-nk/>, <https://onco.cc/trials/nct07324629/>, <https://onco.cc/trials/nct05683886/> ;
  onco:standardOfCare <https://onco.cc/technologies/robotic-surgery/>, <https://onco.cc/technologies/imrt-igrt/>, <https://onco.cc/technologies/proton-therapy/>, <https://onco.cc/drugs/carboplatin/>, <https://onco.cc/drugs/paclitaxel/>, <https://onco.cc/drugs/cisplatin/>, <https://onco.cc/drugs/doxorubicin/>, <https://onco.cc/drugs/cyclophosphamide/>, <https://onco.cc/drugs/carboplatin/>, <https://onco.cc/drugs/paclitaxel/>, <https://onco.cc/technologies/cytotoxic-chemotherapy/>, <https://onco.cc/drugs/sunitinib/>, <https://onco.cc/drugs/lenvatinib/>, <https://onco.cc/drugs/pembrolizumab/>, <https://onco.cc/drugs/everolimus/>, <https://onco.cc/drugs/imatinib/>, <https://onco.cc/terms/irae/>, <https://onco.cc/technologies/kinase-inhibitors/>, <https://onco.cc/technologies/checkpoint-inhibitor/>, <https://onco.cc/trials/nct05683886/>, <https://onco.cc/trials/nct07324629/>, <https://onco.cc/trials/nct07598955/>, <https://onco.cc/drugs/kc1036/>, <https://onco.cc/drugs/eb-car30-nk/> .